International Biotechnology Trust’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-40,000
| Closed | -$2.26M | – | 77 |
|
2021
Q3 | $2.26M | Buy |
40,000
+5,953
| +17% | +$337K | 0.55% | 38 |
|
2021
Q2 | $1.5M | Buy |
+34,047
| New | +$1.5M | 0.4% | 44 |
|
2020
Q3 | – | Sell |
-46,500
| Closed | -$2.28M | – | 54 |
|
2020
Q2 | $2.28M | Hold |
46,500
| – | – | 0.76% | 25 |
|
2020
Q1 | $2.39M | Buy |
+46,500
| New | +$2.39M | 1.09% | 22 |
|
2019
Q2 | – | Sell |
-61,000
| Closed | -$5.83M | – | 65 |
|
2019
Q1 | $5.83M | Buy |
61,000
+18,000
| +42% | +$1.72M | 2.15% | 16 |
|
2018
Q4 | $2.39M | Buy |
+43,000
| New | +$2.39M | 1.48% | 22 |
|